Parteck® CCS Croscarmellose Sodium

Description

Parteck® CCS excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is a superdisintegrant and suitable for use in capsule formulation, wet granulation, roller compaction and direct compression. As Emprove® Essential excipient, it is a high quality pharmaceutical excipient, offered with extensive documentation facilitating compliance, full supply chain transparency and risk mitigation.

Superdisintegrant for Solid Formulations

To support your formulation needs, we are able to offer a complete disintegrants portfolio, which includes our Parteck® CCS (Croscarmellose Sodium), a cross-linked carboxymethylcellulose, for use as a superdisintegrant in pharmaceutical formulations. Unlike conventional disintegrants, Parteck® CCS can be utilized in low concentrations and still impart exceptional disintegrating properties to the final dosage forms.

Benefits:

• Faster disintegration due to large particle size
• Does not contain peroxides – for better API stability
• Fast water absorption
• Flexible in use
• Good tablet dissolution for a wide variety of applications
• Emprove® documentation and regulatory services

Faster Disintegration for Immediate Release Tablets

Parteck® CCS is used to aid in faster disintegration of tablets as required for immediate release tablets, fast release tablets, orally disintegrating tablets and sublingual tablets. Contact with water leads to the swelling of Croscarmellose Sodium which results in the mechanical expansion of the tablet, resulting in faster disintegration. It can be used in direct compression, roller compaction or wet granulations as well as in capsule formulation. And with Parteck® CCS, you can be confident of batch-to-batch consistency.

Parteck® CCS is part of the Emprove® exp program, which combines outstanding quality with comprehensive documentation and excellent services for swift approval processes and faster time to market.